Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule |
Is a |
Product containing papaveretum and scopolamine hydrobromide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Opium preparation |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Papaveretum (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Opium |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Central nervous system agent (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule |
Has manufactured dose form |
Injection (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hyoscine hydrobromide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule |
Is a |
Product containing scopolamine in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule |
Has manufactured dose form |
Injection solution (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|